214 related articles for article (PubMed ID: 33762177)
1. ApoA5 lowers triglyceride levels via suppression of ANGPTL3/8-mediated LPL inhibition.
Chen YQ; Pottanat TG; Zhen EY; Siegel RW; Ehsani M; Qian YW; Konrad RJ
J Lipid Res; 2021; 62():100068. PubMed ID: 33762177
[TBL] [Abstract][Full Text] [Related]
2. An anti-ANGPTL3/8 antibody decreases circulating triglycerides by binding to a LPL-inhibitory leucine zipper-like motif.
Balasubramaniam D; Schroeder O; Russell AM; Fitchett JR; Austin AK; Beyer TP; Chen YQ; Day JW; Ehsani M; Heng AR; Zhen EY; Davies J; Glaesner W; Jones BE; Siegel RW; Qian YW; Konrad RJ
J Lipid Res; 2022 May; 63(5):100198. PubMed ID: 35307397
[TBL] [Abstract][Full Text] [Related]
3. Angiopoietin-like protein 8: a multifaceted protein instrumental in regulating triglyceride metabolism.
Wen Y; Chen YQ; Konrad RJ
Curr Opin Lipidol; 2024 Apr; 35(2):58-65. PubMed ID: 37962908
[TBL] [Abstract][Full Text] [Related]
4. Carboxyl-terminal sequences in APOA5 are important for suppressing ANGPTL3/8 activity.
Chen YQ; Yang Y; Zhen EY; Beyer TP; Li H; Wen Y; Ehsani M; Jackson N; Xie K; Jung H; Scheithauer JL; Kumari A; Birrane G; Russell AM; Balasubramaniam D; Liao Z; Siegel RW; Qian Y; Ploug M; Young SG; Konrad RJ
Proc Natl Acad Sci U S A; 2024 Apr; 121(17):e2322332121. PubMed ID: 38625948
[TBL] [Abstract][Full Text] [Related]
5. Angiopoietin-like proteins and postprandial partitioning of fatty acids.
DiDonna NM; Chen YQ; Konrad RJ
Curr Opin Lipidol; 2022 Feb; 33(1):39-46. PubMed ID: 34789669
[TBL] [Abstract][Full Text] [Related]
6. Angiopoietin-like 3 inhibition of endothelial lipase is not modulated by angiopoietin-like 8.
Sylvers-Davie KL; Segura-Roman A; Salvi AM; Schache KJ; Davies BSJ
J Lipid Res; 2021; 62():100112. PubMed ID: 34461133
[TBL] [Abstract][Full Text] [Related]
7. Angiopoietin-like protein 8 differentially regulates ANGPTL3 and ANGPTL4 during postprandial partitioning of fatty acids.
Chen YQ; Pottanat TG; Siegel RW; Ehsani M; Qian YW; Zhen EY; Regmi A; Roell WC; Guo H; Luo MJ; Gimeno RE; Van't Hooft F; Konrad RJ
J Lipid Res; 2020 Aug; 61(8):1203-1220. PubMed ID: 32487544
[TBL] [Abstract][Full Text] [Related]
8. Genetic Mimicry Analysis Reveals the Specific Lipases Targeted by the ANGPTL3-ANGPTL8 Complex and ANGPTL4.
Landfors F; Chorell E; Kersten S
J Lipid Res; 2023 Jan; 64(1):100313. PubMed ID: 36372100
[TBL] [Abstract][Full Text] [Related]
9. ANGPTL8 requires ANGPTL3 to inhibit lipoprotein lipase and plasma triglyceride clearance.
Haller JF; Mintah IJ; Shihanian LM; Stevis P; Buckler D; Alexa-Braun CA; Kleiner S; Banfi S; Cohen JC; Hobbs HH; Yancopoulos GD; Murphy AJ; Gusarova V; Gromada J
J Lipid Res; 2017 Jun; 58(6):1166-1173. PubMed ID: 28413163
[TBL] [Abstract][Full Text] [Related]
10. APOA5 Deficiency Causes Hypertriglyceridemia by Reducing Amounts of Lipoprotein Lipase in Capillaries.
Yang Y; Konrad RJ; Ploug M; Young SG
J Lipid Res; 2024 Jun; ():100578. PubMed ID: 38880127
[TBL] [Abstract][Full Text] [Related]
11. ANGPTL8 promotes the ability of ANGPTL3 to bind and inhibit lipoprotein lipase.
Chi X; Britt EC; Shows HW; Hjelmaas AJ; Shetty SK; Cushing EM; Li W; Dou A; Zhang R; Davies BSJ
Mol Metab; 2017 Oct; 6(10):1137-1149. PubMed ID: 29031715
[TBL] [Abstract][Full Text] [Related]
12. Decoding the role of angiopoietin-like protein 4/8 complex-mediated plasmin generation in the regulation of LPL activity.
Chen YQ; Zhen EY; Russell AM; Ehsani M; Siegel RW; Qian Y; Konrad RJ
J Lipid Res; 2023 Oct; 64(10):100441. PubMed ID: 37666362
[TBL] [Abstract][Full Text] [Related]
13. Relationship between Serum Angiopoietin-like Proteins 3 and 8 and Atherogenic Lipid Biomarkers in Non-Diabetic Adults Depends on Gender and Obesity.
Murawska K; Krintus M; Kuligowska-Prusinska M; Szternel L; Stefanska A; Sypniewska G
Nutrients; 2021 Nov; 13(12):. PubMed ID: 34959891
[TBL] [Abstract][Full Text] [Related]
14. A unified model for regulating lipoprotein lipase activity.
Zhang R; Zhang K
Trends Endocrinol Metab; 2024 Jun; 35(6):490-504. PubMed ID: 38521668
[TBL] [Abstract][Full Text] [Related]
15. Identification of a new functional domain in angiopoietin-like 3 (ANGPTL3) and angiopoietin-like 4 (ANGPTL4) involved in binding and inhibition of lipoprotein lipase (LPL).
Lee EC; Desai U; Gololobov G; Hong S; Feng X; Yu XC; Gay J; Wilganowski N; Gao C; Du LL; Chen J; Hu Y; Zhao S; Kirkpatrick L; Schneider M; Zambrowicz BP; Landes G; Powell DR; Sonnenburg WK
J Biol Chem; 2009 May; 284(20):13735-13745. PubMed ID: 19318355
[TBL] [Abstract][Full Text] [Related]
16. The ANGPTL3-4-8 model, a molecular mechanism for triglyceride trafficking.
Zhang R
Open Biol; 2016 Apr; 6(4):150272. PubMed ID: 27053679
[TBL] [Abstract][Full Text] [Related]
17. Angiopoietin-like protein 4(E40K) and ANGPTL4/8 complex have reduced, temperature-dependent LPL-inhibitory activity compared to ANGPTL4.
Chen YQ; Pottanat TG; Siegel RW; Ehsani M; Qian YW; Roell WC; Konrad RJ
Biochem Biophys Res Commun; 2021 Jan; 534():498-503. PubMed ID: 33239171
[TBL] [Abstract][Full Text] [Related]
18. A VLP-based vaccine targeting ANGPTL3 lowers plasma triglycerides in mice.
Fowler A; Sampson M; Remaley AT; Chackerian B
Vaccine; 2021 Sep; 39(40):5780-5786. PubMed ID: 34474934
[TBL] [Abstract][Full Text] [Related]
19. An updated ANGPTL3-4-8 model as a mechanism of triglyceride partitioning between fat and oxidative tissues.
Zhang R; Zhang K
Prog Lipid Res; 2022 Jan; 85():101140. PubMed ID: 34793860
[TBL] [Abstract][Full Text] [Related]
20. On the mechanism of angiopoietin-like protein 8 for control of lipoprotein lipase activity.
Kovrov O; Kristensen KK; Larsson E; Ploug M; Olivecrona G
J Lipid Res; 2019 Apr; 60(4):783-793. PubMed ID: 30686789
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
